From 30% to 50% of prescribed medications are not used in line with doctors` recommendations. In result of non-adherence, patients will experience decreased effectiveness of treatment which can lead to the worsening of their condition. The non-adherence to dabigatran varies from 22% to 43%, and is associated with worse outcome in patients with atrial fibrillation.
The current study examined how pharmacist counselling with motivational interviewing, pictogram-enhanced medication instructions, and Smartphone medication reminders can improve adherence to patients being treated for atrial fibrillation. Across all time points there was a significantly higher proportion of patients in the Intervention Group who did not miss a daily dose and who were adherent to the prescribed dose (twice/day) of dabigatran when compared to Controls. Our findings support the role for a pharmacist-led intervention to improve adherence to dabigatran, thus providing evidence for the efficacy of a pharmacist-led pictogram and smartphone-based program to improve medication adherence.
Dr Piotr Merks is a Polish licensed Pharmacist, Adjunct Professor at the Department of Pharmacology and Clinical Pharmacology at the Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszyński University in Warsaw, Poland, Advisor of The Management Board at the Polish Pharmaceutical Group (PGF S.A.) one of the largest polish wholesalers, funder and CEO of Piktorex limited company funded by the National Center for Research Development in Poland and Black Pearls VC. Holds international expertise in various pharmacy sectors: educational facilities, governmental and non-governmental bodies, pharmaceutical companies, hospitals, community pharmacies. As an educator and innovator Piotr works to empower pharmaceutical scientists and pharmacists as the future leaders in healthcare.
Piotr first started his career as a registered Pharmacist in the UK primary care setting delivering public health interventions to patient in underserved communities across the UK. It was his early experience in practice that inspired him to conduct research in social pharmacy, before moving into the academic sector full time in 2011. He went on to earn his Ph.D in pharmaceutical care services, at the Nicolaus Copernicus University in Poland, and achieved his degree in 2017. Piotr launched the Polish Pharmacy Trade Union (ZZPF) to fight for the rights of employees in pharmacy sector in Poland. Since 2012 he raises awareness around the falsified medicines in Poland, first as a country Ambassador and later as Business Development Director of Aegate Limited UK, now as an external independent expert.
Dr Merks has presented widely at national and international meetings and is a recognized leader across the pharmacy profession and, more widely, in science, pharmaceutical technology and innovation. He is also working closely with FIP on development of pharmaceutical pictograms, and Polish pharmacy sector as an Advisor. His work, research and leadership, have been recognized internationally, and he is being invited to many international events as a guest speaker. Throughout his career Piotr has acted as a passionate advocate for the pharmacy profession and has partnered with stakeholders across sectors to align the pharmacy workforce with the Sustainable Development Goals to make an embracing change for the pharmacy as a profession.